Top Stocks to Buy this Year

Every year, I ask our contributors to Wall Street’s Best Dividend Stocks and Wall Street’s Best Investments to select the one investment that they believe will be their biggest winner that year. And earlier this month, I published the winners in our special Picks...
Read More

OncoGenex Pharmaceuticals (OGXI)

This biopharmaceutical company has two drug candidates in clinical development across multiple oncology therapeutic areas and a candidate in pre-clinical development. OncoGenex’Pharmaceuticals (OGXI) from The Medical Technology Stock Letter OncoGenex Pharmaceuticals’ (OGXI ) custirsen could dominate second-line hormone resistant prostate cancer (HRPC) therapy. Medivation’s Xtandi has positive...
Read More